BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Biotechnology Magazine - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:European Biotechnology Magazine
X-ORIGINAL-URL:https://european-biotechnology.com
X-WR-CALDESC:Events for European Biotechnology Magazine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260929
DTEND;VALUE=DATE:20261002
DTSTAMP:20260806T045601
CREATED:20260616T115914Z
LAST-MODIFIED:20260616T115914Z
UID:20767-1790640000-1790899199@european-biotechnology.com
SUMMARY:BIOSPAIN 2026
DESCRIPTION:BIOSPAIN 2026 will take place from 29 September to 1 October at the Bilbao Exhibition Centre (BEC)\, bringing together the global biotechnology community under the claim “Bioinnovation that clicks.” Organized by AseBio in collaboration with the Provincial Council of Bizkaia\, the Basque Government and the Basque Health Cluster\, the event reinforces its role as Spain’s flagship biotech congress and one of Europe’s leading life sciences gatherings. \nFor the first time in its history\, BIOSPAIN becomes an annual event\, reflecting the sector’s growing momentum and international demand. The 2025 edition in Barcelona welcomed more than 2\,400 attendees from 35 countries\, confirming BIOSPAIN as a premier platform for business development\, investment and strategic networking. \nHosted for the third time in the Basque Country\, BIOSPAIN 2026 will showcase one of Europe’s most dynamic life sciences ecosystems\, home to more than 300 companies\, 20 research centers\, four universities and world-class hospitals. \nThe programme will address key scientific\, industrial and regulatory trends shaping biotechnology\, including advanced therapies\, AI-driven drug development\, CRISPR\, RNA technologies\, foodtech\, sustainable bioeconomy\, biomanufacturing and European biotech policy. \nWith partnering opportunities\, international investors\, exhibition space and a dedicated Talent Day\, BIOSPAIN 2026 will offer a unique platform to connect innovation\, business and talent.
URL:https://european-biotechnology.com/highlight/biospain-2026/
LOCATION:Bilbao
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/06/BIOSPAIN_Barcelona_2025-scaled-e1781611090578.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261015
DTSTAMP:20260806T045601
CREATED:20260526T131604Z
LAST-MODIFIED:20260616T120343Z
UID:20450-1791849600-1792022399@european-biotechnology.com
SUMMARY:BIOTECH SUMMIT AUSTRIA 2026
DESCRIPTION:The BIOTECH SUMMIT AUSTRIA returns on October 13–14\, 2026\, bringing Austria’s and Europe’s biotech community together in Innsbruck. As one of the country’s key platforms for biotechnology\, the summit connects leading voices from science\, industry\, startups\, investment\, policy and the wider life science ecosystem – creating a space where ideas\, expertise and partnerships can grow. \nAt the heart of the conference is a central question for the biotech sector: How can excellent science be translated into successful applications\, strong companies and sustainable value creation? Austria has a dynamic and highly innovative biotech landscape\, with outstanding academic research\, ambitious startups\, experienced industry players and a growing network of investors\, experts and support organizations. The BIOTECH SUMMIT AUSTRIA makes this potential visible and brings together the people who can help turn it into real impact. \nThe program offers a carefully curated mix of keynotes\, panel discussions\, workshops\, startup and expert formats\, as well as numerous opportunities for personal B2B meetings. Topics will range from translational research\, financing and scaling to international markets\, collaboration models and the conditions needed to strengthen Austria’s biotech ecosystem. \nA particular strength of the summit is its focus on meaningful personal exchange. Structured 1:1 meetings\, networking sessions and informal encounters provide the ideal setting to meet potential partners\, explore new opportunities and deepen existing relationships. Whether participants are looking for investment\, scientific collaboration\, business development opportunities or fresh perspectives from across the sector\, the summit offers a highly relevant platform for connection and dialogue. \nThe BIOTECH SUMMIT AUSTRIA is a joint initiative of BIOTECH AUSTRIA\, Human.technology Styria and Health Hub Tirol / Standortagentur Tirol. The conference language is English. \nContact\, more information & registration:\nwww.biotech-summit-austria.com\nsummit@biotechaustria.org
URL:https://european-biotechnology.com/highlight/biotech-summit-austria-2026/
LOCATION:Innsbruck
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/05/BSA26-Event-Highlight-960x540-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261014
DTEND;VALUE=DATE:20261016
DTSTAMP:20260806T045601
CREATED:20260717T094032Z
LAST-MODIFIED:20260720T145718Z
UID:21212-1791936000-1792108799@european-biotechnology.com
SUMMARY:20 Years of Connecting Drug Discovery
DESCRIPTION:For twenty years\, ELRIG’s Drug Discovery conference has provided a unique meeting place where scientists from academia\, biotech\, pharma\, CROs and technology providers come together to exchange ideas\, build collaborations and accelerate innovation. \nThis October\, the conference returns to ExCeL\, London to celebrate its 20th anniversary\, marking two decades of supporting the global drug discovery community through open access\, collaboration and scientific excellence. What began as a grassroots initiative has grown into Europe’s largest free-to-attend drug discovery event\, welcoming thousands of delegates each year while remaining true to its founding principles of accessibility\, inclusivity and community. \nDrug Discovery 2026 will feature a 14 track\, exceptional scientific programme spanning the full discovery pipeline\, from target identification and validation through to translational science\, advanced therapeutics and enabling technologies. Delegates will have the opportunity to explore the latest advances in AI-enabled drug discovery\, biophysics\, medicinal chemistry\, microbiology\, cell and gene therapies\, automation\, next-generation screening technologies\, multi-omics and much more. \nThe milestone event will also feature one of its strongest keynote programmes to date. Day one will open with keynote speaker Sam Barrell CBE (LifeArc). On day two\, for the first time in the conference’s history\, ELRIG will host a keynote panel\, featuring Dr Anne Phelan (GSK)\, Dr Jason Mellad (OtoImmune)\, Professor Sir Mene Pangalos (AstraZeneca) and Professor Raghib Ali OBE (Our Future Health). Chaired by Dr Saleha Patel (ELRIG and Constructive Bio)\, the panel will bring together leaders from across industry\, biotech and healthcare to discuss the opportunities\, challenges and innovations shaping the future of drug discovery. \nAs a volunteer-led\, not-for-profit organisation\, ELRIG continues to believe that the best science happens when knowledge is shared openly. Free registration ensures researchers from every career stage and every part of the life science ecosystem can participate\, creating an environment where new ideas\, partnerships and innovations flourish. \nWhether you are an established researcher\, an early-career scientist\, a technology developer or a commercial partner\, Drug Discovery 2026 offers an unparalleled opportunity to learn from world-leading experts\, discover emerging technologies\, expand your professional network and help shape the next generation of medicines. \nJoin us at ExCeL London on 14–15 October 2026 as we celebrate twenty years of collaboration – and look ahead to the next twenty years of discovery.
URL:https://european-biotechnology.com/highlight/20-years-of-connecting-drug-discovery/
LOCATION:London\, United Kingdom
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/07/Drug-discovery-ELRIG-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261109
DTEND;VALUE=DATE:20261112
DTSTAMP:20260806T045601
CREATED:20260604T133938Z
LAST-MODIFIED:20260604T133938Z
UID:20630-1794182400-1794441599@european-biotechnology.com
SUMMARY:BIO-Europe 2026
DESCRIPTION:BIO-Europe 2026 strengthens life science leadership\, champions innovation\, and fosters the global partnerships that drive our industry forward. As the landscape evolves\, we’re expanding to meet the needs of the entire biotech ecosystem. \nThe vision for BIO-Europe 2026 convenes the entire biotech pharma C-suite. Six parallel content tracks expand on partnering and investment and therapeutic area topics to include regulatory developments\, clinical affairs\, and manufacturing strategy. Daily plenary sessions address macro-level industry and policy trends impacting global life science leadership\, and new access options support different levels of delegate engagement. \nAt the heart of this vision is our unwavering commitment to global collaboration. BIO-Europe 2026 stands for open dialogue\, building partnerships\, and advancing R&D that improves patient outcomes worldwide. \nTo support the new content tracks\, a new Content-Only registration is available. This non-partnering pass brings BIO-Europe to your whole C-suite. Content-Only attendees will have access to the exhibit hall\, all program tracks\, and the Monday evening event\, while All-Access attendees enjoy the full partnering experience. \nEvent website:\ninformaconnect.com/bioeurope/ \nEmail:\ncssupport1@informa.com \n  \n 
URL:https://european-biotechnology.com/highlight/bio-europe-2026/
LOCATION:Cologne
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/06/eb.com_BIO-Europe-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261112
DTEND;VALUE=DATE:20261114
DTSTAMP:20260806T045601
CREATED:20260706T100316Z
LAST-MODIFIED:20260706T100316Z
UID:21055-1794441600-1794614399@european-biotechnology.com
SUMMARY:How Will Theranostics Shape Patient Care Within 5 Years?
DESCRIPTION:Following the outstanding success of its 2nd edition in 2024\, which brought together more than 400 participants from around the world\, the ICPO Foundation is proud to announce the next ICPO Theranostics Virtual Summit 2026 on November 12 &13\, 2026. This must-attend online scientific event will once again unite hundreds of international healthcare professionals\, researchers\, and industry leaders. \nThe three Chairs of the ICPO Summit will guide you through this online event and will interact with you live from the ICPO studio: Prof. Richard P. Baum\, President of ICPO Academy for Theranostics\, Chairman of the Scientific Advisory Board of the ICPO Foundation and Nuclear Medicine Physician at Curanosticum Wiesbaden Germany; Prof. Frederik L. Giesel\, University Hospital Duesseldorf\, Germany\, Co-Chair ICPO Scientific Advisory Board and Prof. Rudolf A. Werner\, Head of Nuclear Medicine\, LMU Clinic Munich\, Germany. \nDuring the ICPO Summit 2026 attendees from around the globe have the opportunity to engage live with the chairs and speakers in an interactive virtual setting. The program features five key Theranostics themes: \n\nRising stars in Theranostics – Beyond PSMA and FAP\nGrowing space of Alphas – Outlook on untapped potential\nClinical trials planning – Navigate from hurdles to outcomes\nLeveraging AI in Theranostics – Advancing clinical practice globally\nRecommendations to grow patient access to Theranostics over the next 5 years\n\nThe ICPO Summit 2026 is designed for healthcare professionals\, researchers\, and industry experts involved in the rapidly evolving field of Theranostics and precision oncology committed to advancing innovative diagnostic and therapeutic approaches for cancer care. The event is particularly relevant for nuclear medicine physicians\, oncologists\, radiologists\, radiopharmacists\, medical physicists\, and clinical researchers seeking to stay informed about the latest developments in Theranostics. \nPlease have a look at the program and register: ICPO Theranostics Virtual Summit 2026 \nContact:\nICPO Foundation\nEmail: info@icpo.foundation \n 
URL:https://european-biotechnology.com/highlight/how-will-theranostics-shape-patient-care-within-5-years/
CATEGORIES:highlight
ATTACH;FMTTYPE=image/png:https://european-biotechnology.com/wp-content/uploads/2026/07/EBN-Website-Banner-ICPO-Summit-2026.png
ORGANIZER;CN="ICPO Foundation":MAILTO:info@icpo.foundation
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261123
DTEND;VALUE=DATE:20261126
DTSTAMP:20260806T045601
CREATED:20260213T130059Z
LAST-MODIFIED:20260604T073701Z
UID:19338-1795392000-1795651199@european-biotechnology.com
SUMMARY:PharmaLab Congress and Exhibition 2026 at a new venue
DESCRIPTION:Named after the chemical element Darmstadtium (Ds110)\, it combines the 1\,302 m² spectrum congress hall for exhibition stands with 3\,700 m² of light-flooded foyer space\, giving exhibitors an ideal setting to connect with PharmaLab Congress delegates and exhibition visitors. \nIn 2026\, a new topic will be addressed in a dedicated track: \n– Data Quality Management of Aberrant Results – Handling Out of Specification\, OOS\, and Out of Trend\, OOT results (Pre-Conference\, 23 November ) \nThe established topics will also be covered at PharmaLab 2026 from 23-25 November in Darmstadt – providing participants with the opportunity to exchange knowledge and experiences with representatives from authorities\, industrial experts and scientists from laboratories: \n\nAnalytical Procedure Lifecycle Management (APLM)\nGMP Compliance Trends Analytical Laboratories\nLaboratory Optimization\, Automation and Digitalization/Outsourcing in Pharmaceutical Laboratories\nEndotoxin and Pyrogen Testing\nAlternative and Rapid Microbiological Methods\nCell and Gene Therapies/ ATMPs – Quality and Safety\nBioassays/Potency Assays – Regulatory Requirements\, Developments and Routine Use\nBioanalytical Control of Biological Drug Substances and Products\nQuality Control of mRNA/LNP Products (Pre-Conference\, 23 November)\n7th International Mycoplasma qPCR Testing User Day (Pre-Conference\, 23 November)\n\n\nCongress delegates benefit from 9 parallel conferences\, 3 pre-conference workshops with altogether over 100 presentations\, over 60 exhibitors in the exhibition and the networking event. An update in all relevant areas of pharmaceutical lab developments will be provided. We are also open for poster submissions for the exhibition. \nOne-day and multi-day tickets offer participants the opportunity to attend parts or even the entire congress and thereby put together an individual programme with the lectures of choice. \nWe look forward to welcoming you in Darmstadt at PharmaLab. \nMore information \nWebsite: https://www.pharmalab-congress.com\neMail: info@concept-heidelberg.de
URL:https://european-biotechnology.com/highlight/pharmalab-2026-congress-exhibition/
LOCATION:Darmstadt
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/02/PharmaLab2026_ebm-transkript-event-highlight.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270203
DTEND;VALUE=DATE:20270204
DTSTAMP:20260806T045601
CREATED:20260714T112558Z
LAST-MODIFIED:20260714T112558Z
UID:21156-1801612800-1801699199@european-biotechnology.com
SUMMARY:life – the biomedical convention 2027
DESCRIPTION:Dive into one of Europe’s most vibrant life science ecosystems \nOn 3 February 2027\, life – the biomedical convention returns to the Heidelberg Congress Center\, bringing together around 500 scientists\, entrepreneurs\, investors and industry leaders from across Germany and neighbouring countries. \nHosted by bioRN Life Science Cluster\, the conference offers a unique gateway into one of Europe’s strongest life science ecosystems. The Rhine-Neckar region combines world-class research institutions\, global pharmaceutical companies\, innovative SMEs and a rapidly growing startup community—creating an environment where scientific excellence meets entrepreneurship and where biomedical innovation is translated into real-world impact. \nThe scientific programme is built around two complementary tracks. Biomedical Innovations highlights breakthrough research\, novel technologies and translational success stories emerging from the region’s vibrant ecosystem. AI in Health explores how artificial intelligence is reshaping every stage of biomedical innovation—from AI-driven drug discovery and computational biology to digital pathology\, precision medicine and data-driven diagnostics. Beyond technological advances\, the programme will also address key questions surrounding regulation\, data integration and the evolving role of researchers\, clinicians and industry as AI becomes an integral part of healthcare. \nMore than 30 exhibitors will showcase the latest technologies\, services and innovations\, while the exhibition area serves as a lively meeting point throughout the day. Short Lunch Talks provide practical learning nuggets during the breaks\, offering fresh perspectives on emerging technologies\, entrepreneurship and innovation in concise\, inspiring sessions. \nA particular highlight is the Young Scientists Pitch Competition\, where outstanding early-career researchers present their most promising ideas to an expert jury and an audience of leading decision-makers from academia and industry—creating visibility for the next generation of biomedical innovators. \nWhat truly distinguishes life is its exceptional networking atmosphere. With representatives from approximately 200 companies\, research institutes and organisations\, the convention offers countless opportunities to exchange ideas\, establish new collaborations\, meet future partners and expand professional networks—all within a single day. \nNot the biggest conference. Perhaps the most connected. \nWhether you are looking for scientific inspiration\, strategic partnerships\, investment opportunities or simply want to experience one of Europe’s most dynamic life science regions firsthand\, life – the biomedical convention 2027 is the place to be. Join us in Heidelberg and become part of the conversations shaping the future of biomedicine.
URL:https://european-biotechnology.com/highlight/life-the-biomedical-convention-2027/
LOCATION:Heidelberg Congress Center\, Heidelberg\, Germany
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/07/Tap-into-one-of-the-most-vibrant-Life-Science-ecosystems-in-Europe.jpg
ORGANIZER;CN="BioRN":MAILTO:https://biorn.org/
END:VEVENT
END:VCALENDAR